Evidence map›Paper›PMID 34883826›Full record

ReviewSensors (Basel, Switzerland)2021

Biosensors as Nano-Analytical Tools for COVID-19 Detection.

Anchal Pradhan, Preeti Lahare, Priyank Sinha, Namrata Singh, Bhanushree Gupta, Kamil Kuca, Kallol K Ghosh, Ondrej Krejcar

Open access · goldAbstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Review
  8. Insight of smart biosensors for COVID-19: A review.Luminescence : the journal of biological and chemical luminescence · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Recent advances in point of care testing for COVID-19 detection.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Anchal PradhanCenter for Basic Sciences, Department of Chemistry, Pt. Ravishankar Shukla University, Raipur 492010, India.
Preeti LahareCenter for Basic Sciences, Department of Chemistry, Pt. Ravishankar Shukla University, Raipur 492010, India.
Priyank SinhaCenter for Basic Sciences, Department of Chemistry, Pt. Ravishankar Shukla University, Raipur 492010, India.ORCID 0000-0003-4331-8978
Namrata SinghRamrao Adik Institute of Technology, DY Patil University, Nerul, Navi Mumbai 400706, India.ORCID 0000-0002-4628-7137
Bhanushree GuptaCenter for Basic Sciences, Department of Chemistry, Pt. Ravishankar Shukla University, Raipur 492010, India.
Kamil KucaDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic.ORCID 0000-0001-9664-1109
Kallol K GhoshCenter for Basic Sciences, Department of Chemistry, Pt. Ravishankar Shukla University, Raipur 492010, India.
Ondrej KrejcarCenter for Basic and Applied Research, Faculty of Informatics and Management, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic.ORCID 0000-0002-5992-2574
Pandit Ravishankar Shukla University · IND.Y. Patil University · INUniversity Hospital Hradec Králové · CZUniversity of Hradec Králové · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective, sensitive and affordable techniques to detect disease and underlying health issues have been developed recently. Biosensors as nanoanalytical tools have taken a front seat in this context. Nanotechnology-enabled progress in the health sector has aided in disease and pandemic management at a very early stage efficiently. This report reflects the state-of-the-art of nanobiosensor-based virus detection technology in terms of their detection methods, targets, limits of detection, range, sensitivity, assay time, etc. The article effectively summarizes the challenges with traditional technologies and newly emerging biosensors, including the nanotechnology-based detection kit for COVID-19; optically enhanced technology; and electrochemical, smart and wearable enabled nanobiosensors. The less explored but crucial piezoelectric nanobiosensor and the reverse transcription-loop mediated isothermal amplification (RT-LAMP)-based biosensor are also discussed here. The article could be of significance to researchers and doctors dedicated to developing potent, versatile biosensors for the rapid identification of COVID-19. This kind of report is needed for selecting suitable treatments and to avert epidemics.

Indexed as

Biosensing TechniquesCOVID-19HumansNanotechnologyNucleic Acid Amplification TechniquesPandemicsSARS-CoV-2Sensitivity and SpecificityCOVID-19 detectionelectrochemicalnanobiosensoropticalpiezoelectricRT-LAMPsmart and wearable

Identifiers

PMID34883826
PMCPMC8659776
OpenAlexW3216791035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.